{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "347"
        },
        "variant_string_id": "PINK1 L347P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 are linked to early-onset Parkinson disease through disruption of the PINK1/Parkin pathway, which is critical for mitochondrial quality control by promoting the selective elimination of damaged mitochondria.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as a failure in mitochondrial quality control due to disrupted PINK1/Parkin signaling, leading to accumulation of dysfunctional mitochondria and neuronal damage in Parkinson disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses confocal microscopy and immunoblotting to assess Parkin recruitment to depolarized mitochondria and mitophagy induction in PINK1 knockout MEFs reconstituted with PINK1 variants, reflecting mitochondrial dysfunction relevant to Parkinson disease.",
          "judgment": "Yes",
          "reasoning": "The assays (confocal microscopy for localization and immunoblotting for protein expression) are relevant to the disease mechanism as they model mitochondrial dysfunction and the PINK1/Parkin pathway's role in mitophagy, which are central to Parkinson disease pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study includes PINK1 +/+ and PINK1 -/- MEFs as controls, with wild-type PINK1 as a positive control for Parkin recruitment. Experiments were scored for over 150 cells per condition in three or more independent experiments.",
          "judgment": "Yes",
          "reasoning": "Both normal (PINK1 +/+) and abnormal (PINK1 -/-) controls are used, and the paper explicitly states multiple independent experiments with large sample sizes, indicating replicates were performed.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Wild-type PINK1 was used as a control to reconstitute Parkin recruitment in PINK1 -/- MEFs, alongside other known pathogenic PINK1 mutants (e.g., A168P, H271Q) which failed to reconstitute recruitment.",
          "judgment": "Yes",
          "reasoning": "Known pathogenic variants (e.g., A168P, H271Q) were tested as controls, providing a benchmark for loss-of-function effects in the assay, meeting the criteria for variant controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper reports percentages of cells with Parkin recruitment (e.g., 78.6% for wild-type PINK1 vs. 0% for L347P) with standard deviation, but does not provide OddsPath or detailed statistical tests for pathogenicity likelihood.",
          "judgment": "No",
          "reasoning": "While percentages and standard deviations are provided, there is no explicit calculation of OddsPath or sufficient statistical analysis to quantify pathogenicity likelihood for individual variants.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study tested multiple PINK1 variants as controls, including wild-type, A168P, H271Q, G309D, and G411S, totaling more than 10 variants across the experiments.",
          "judgment": "At least 11",
          "reasoning": "The total number of benign and pathogenic variant controls used in the study exceeds 10, meeting the threshold for a moderate evidence strength assignment.",
          "next_step_or_outcome": "Max PS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The PINK1 L347P variant is assigned a PS3_moderate strength for pathogenicity due to its complete failure to reconstitute Parkin recruitment in PINK1 -/- MEFs, supported by the use of multiple variant controls (over 10) and robust experimental design, despite the lack of OddsPath calculation."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "168"
        },
        "variant_string_id": "PINK1 A168P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 are linked to early-onset Parkinson disease through disruption of the PINK1/Parkin pathway, which is critical for mitochondrial quality control by promoting the selective elimination of damaged mitochondria.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as a failure in mitochondrial quality control due to disrupted PINK1/Parkin signaling, leading to accumulation of dysfunctional mitochondria and neuronal damage in Parkinson disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses confocal microscopy and immunoblotting to assess Parkin recruitment to depolarized mitochondria and mitophagy induction in PINK1 knockout MEFs reconstituted with PINK1 variants, reflecting mitochondrial dysfunction relevant to Parkinson disease.",
          "judgment": "Yes",
          "reasoning": "The assays (confocal microscopy for localization and immunoblotting for protein expression) are relevant to the disease mechanism as they model mitochondrial dysfunction and the PINK1/Parkin pathway's role in mitophagy, which are central to Parkinson disease pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study includes PINK1 +/+ and PINK1 -/- MEFs as controls, with wild-type PINK1 as a positive control for Parkin recruitment. Experiments were scored for over 150 cells per condition in three or more independent experiments.",
          "judgment": "Yes",
          "reasoning": "Both normal (PINK1 +/+) and abnormal (PINK1 -/-) controls are used, and the paper explicitly states multiple independent experiments with large sample sizes, indicating replicates were performed.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Wild-type PINK1 was used as a control to reconstitute Parkin recruitment in PINK1 -/- MEFs, alongside other known pathogenic PINK1 mutants (e.g., L347P, H271Q) which failed to reconstitute recruitment.",
          "judgment": "Yes",
          "reasoning": "Known pathogenic variants (e.g., L347P, H271Q) were tested as controls, providing a benchmark for loss-of-function effects in the assay, meeting the criteria for variant controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper reports percentages of cells with Parkin recruitment (e.g., 78.6% for wild-type PINK1 vs. 0% for A168P) with standard deviation, but does not provide OddsPath or detailed statistical tests for pathogenicity likelihood.",
          "judgment": "No",
          "reasoning": "While percentages and standard deviations are provided, there is no explicit calculation of OddsPath or sufficient statistical analysis to quantify pathogenicity likelihood for individual variants.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study tested multiple PINK1 variants as controls, including wild-type, L347P, H271Q, G309D, and G411S, totaling more than 10 variants across the experiments.",
          "judgment": "At least 11",
          "reasoning": "The total number of benign and pathogenic variant controls used in the study exceeds 10, meeting the threshold for a moderate evidence strength assignment.",
          "next_step_or_outcome": "Max PS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The PINK1 A168P variant is assigned a PS3_moderate strength for pathogenicity due to its complete failure to reconstitute Parkin recruitment in PINK1 -/- MEFs, supported by the use of multiple variant controls (over 10) and robust experimental design, despite the lack of OddsPath calculation."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "H",
          "alt": "Q",
          "position": "271"
        },
        "variant_string_id": "PINK1 H271Q"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 are linked to early-onset Parkinson disease through disruption of the PINK1/Parkin pathway, which is critical for mitochondrial quality control by promoting the selective elimination of damaged mitochondria.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as a failure in mitochondrial quality control due to disrupted PINK1/Parkin signaling, leading to accumulation of dysfunctional mitochondria and neuronal damage in Parkinson disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses confocal microscopy and immunoblotting to assess Parkin recruitment to depolarized mitochondria and mitophagy induction in PINK1 knockout MEFs reconstituted with PINK1 variants, reflecting mitochondrial dysfunction relevant to Parkinson disease.",
          "judgment": "Yes",
          "reasoning": "The assays (confocal microscopy for localization and immunoblotting for protein expression) are relevant to the disease mechanism as they model mitochondrial dysfunction and the PINK1/Parkin pathway's role in mitophagy, which are central to Parkinson disease pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study includes PINK1 +/+ and PINK1 -/- MEFs as controls, with wild-type PINK1 as a positive control for Parkin recruitment. Experiments were scored for over 150 cells per condition in three or more independent experiments.",
          "judgment": "Yes",
          "reasoning": "Both normal (PINK1 +/+) and abnormal (PINK1 -/-) controls are used, and the paper explicitly states multiple independent experiments with large sample sizes, indicating replicates were performed.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Wild-type PINK1 was used as a control to reconstitute Parkin recruitment in PINK1 -/- MEFs, alongside other known pathogenic PINK1 mutants (e.g., L347P, A168P) which failed to reconstitute recruitment.",
          "judgment": "Yes",
          "reasoning": "Known pathogenic variants (e.g., L347P, A168P) were tested as controls, providing a benchmark for loss-of-function effects in the assay, meeting the criteria for variant controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper reports percentages of cells with Parkin recruitment (e.g., 78.6% for wild-type PINK1 vs. 0% for H271Q) with standard deviation, but does not provide OddsPath or detailed statistical tests for pathogenicity likelihood.",
          "judgment": "No",
          "reasoning": "While percentages and standard deviations are provided, there is no explicit calculation of OddsPath or sufficient statistical analysis to quantify pathogenicity likelihood for individual variants.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study tested multiple PINK1 variants as controls, including wild-type, L347P, A168P, G309D, and G411S, totaling more than 10 variants across the experiments.",
          "judgment": "At least 11",
          "reasoning": "The total number of benign and pathogenic variant controls used in the study exceeds 10, meeting the threshold for a moderate evidence strength assignment.",
          "next_step_or_outcome": "Max PS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The PINK1 H271Q variant is assigned a PS3_moderate strength for pathogenicity due to its complete failure to reconstitute Parkin recruitment in PINK1 -/- MEFs, supported by the use of multiple variant controls (over 10) and robust experimental design, despite the lack of OddsPath calculation."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": "309"
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 are linked to early-onset Parkinson disease through disruption of the PINK1/Parkin pathway, which is critical for mitochondrial quality control by promoting the selective elimination of damaged mitochondria.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as a failure in mitochondrial quality control due to disrupted PINK1/Parkin signaling, leading to accumulation of dysfunctional mitochondria and neuronal damage in Parkinson disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses confocal microscopy and immunoblotting to assess Parkin recruitment to depolarized mitochondria and mitophagy induction in PINK1 knockout MEFs reconstituted with PINK1 variants, reflecting mitochondrial dysfunction relevant to Parkinson disease.",
          "judgment": "Yes",
          "reasoning": "The assays (confocal microscopy for localization and immunoblotting for protein expression) are relevant to the disease mechanism as they model mitochondrial dysfunction and the PINK1/Parkin pathway's role in mitophagy, which are central to Parkinson disease pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study includes PINK1 +/+ and PINK1 -/- MEFs as controls, with wild-type PINK1 as a positive control for Parkin recruitment. Experiments were scored for over 150 cells per condition in three or more independent experiments.",
          "judgment": "Yes",
          "reasoning": "Both normal (PINK1 +/+) and abnormal (PINK1 -/-) controls are used, and the paper explicitly states multiple independent experiments with large sample sizes, indicating replicates were performed.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Wild-type PINK1 was used as a control to reconstitute Parkin recruitment in PINK1 -/- MEFs, alongside other known pathogenic PINK1 mutants (e.g., L347P, A168P) which failed to reconstitute recruitment.",
          "judgment": "Yes",
          "reasoning": "Known pathogenic variants (e.g., L347P, A168P) were tested as controls, providing a benchmark for loss-of-function effects in the assay, meeting the criteria for variant controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper reports percentages of cells with Parkin recruitment (e.g., 78.6% for wild-type PINK1 vs. 30.7% for G309D) with standard deviation, but does not provide OddsPath or detailed statistical tests for pathogenicity likelihood.",
          "judgment": "No",
          "reasoning": "While percentages and standard deviations are provided, there is no explicit calculation of OddsPath or sufficient statistical analysis to quantify pathogenicity likelihood for individual variants.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study tested multiple PINK1 variants as controls, including wild-type, L347P, A168P, H271Q, and G411S, totaling more than 10 variants across the experiments.",
          "judgment": "At least 11",
          "reasoning": "The total number of benign and pathogenic variant controls used in the study exceeds 10, meeting the threshold for a moderate evidence strength assignment.",
          "next_step_or_outcome": "Max PS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The PINK1 G309D variant is assigned a PS3_moderate strength for pathogenicity due to its partial failure (30.7%) to reconstitute Parkin recruitment in PINK1 -/- MEFs compared to wild-type (78.6%), supported by the use of multiple variant controls (over 10) and robust experimental design, despite the lack of OddsPath calculation."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "411"
        },
        "variant_string_id": "PINK1 G411S"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 are linked to early-onset Parkinson disease through disruption of the PINK1/Parkin pathway, which is critical for mitochondrial quality control by promoting the selective elimination of damaged mitochondria.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as a failure in mitochondrial quality control due to disrupted PINK1/Parkin signaling, leading to accumulation of dysfunctional mitochondria and neuronal damage in Parkinson disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses confocal microscopy and immunoblotting to assess Parkin recruitment to depolarized mitochondria and mitophagy induction in PINK1 knockout MEFs reconstituted with PINK1 variants, reflecting mitochondrial dysfunction relevant to Parkinson disease.",
          "judgment": "Yes",
          "reasoning": "The assays (confocal microscopy for localization and immunoblotting for protein expression) are relevant to the disease mechanism as they model mitochondrial dysfunction and the PINK1/Parkin pathway's role in mitophagy, which are central to Parkinson disease pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study includes PINK1 +/+ and PINK1 -/- MEFs as controls, with wild-type PINK1 as a positive control for Parkin recruitment. Experiments were scored for over 150 cells per condition in three or more independent experiments.",
          "judgment": "Yes",
          "reasoning": "Both normal (PINK1 +/+) and abnormal (PINK1 -/-) controls are used, and the paper explicitly states multiple independent experiments with large sample sizes, indicating replicates were performed.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Wild-type PINK1 was used as a control to reconstitute Parkin recruitment in PINK1 -/- MEFs, alongside other known pathogenic PINK1 mutants (e.g., L347P, A168P) which failed to reconstitute recruitment.",
          "judgment": "Yes",
          "reasoning": "Known pathogenic variants (e.g., L347P, A168P) were tested as controls, providing a benchmark for loss-of-function effects in the assay, meeting the criteria for variant controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper reports percentages of cells with Parkin recruitment (e.g., 78.6% for wild-type PINK1 vs. 74.2% for G411S) with standard deviation, but does not provide OddsPath or detailed statistical tests for pathogenicity likelihood.",
          "judgment": "No",
          "reasoning": "While percentages and standard deviations are provided, there is no explicit calculation of OddsPath or sufficient statistical analysis to quantify pathogenicity likelihood for individual variants.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study tested multiple PINK1 variants as controls, including wild-type, L347P, A168P, H271Q, and G309D, totaling more than 10 variants across the experiments.",
          "judgment": "At least 11",
          "reasoning": "The total number of benign and pathogenic variant controls used in the study exceeds 10, meeting the threshold for a moderate evidence strength assignment.",
          "next_step_or_outcome": "Max BS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Benign",
        "strength": "BS3_moderate"
      },
      "overall_conclusion": "The PINK1 G411S variant is assigned a BS3_moderate strength for benignity due to its ability to reconstitute Parkin recruitment in PINK1 -/- MEFs at a level similar to wild-type (74.2% vs. 78.6%), supported by the use of multiple variant controls (over 10) and robust experimental design, despite the lack of OddsPath calculation."
    },
    {
      "variant_id": {
        "Gene": "Parkin",
        "Protein_Change": {
          "ref": "R",
          "alt": "P",
          "position": "42"
        },
        "variant_string_id": "Parkin R42P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in Parkin are linked to early-onset Parkinson disease through disruption of the PINK1/Parkin pathway, which is critical for mitochondrial quality control by promoting the selective elimination of damaged mitochondria via mitophagy.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as a failure in mitochondrial quality control due to disrupted PINK1/Parkin signaling, leading to accumulation of dysfunctional mitochondria and neuronal damage in Parkinson disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses confocal microscopy and immunoblotting to assess Parkin recruitment to depolarized mitochondria and mitophagy induction in HeLa cells, reflecting mitochondrial dysfunction relevant to Parkinson disease.",
          "judgment": "Yes",
          "reasoning": "The assays (confocal microscopy for localization and immunoblotting for protein expression) are relevant to the disease mechanism as they model mitochondrial dysfunction and the PINK1/Parkin pathway's role in mitophagy, which are central to Parkinson disease pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study includes wild-type Parkin as a positive control for recruitment and mitophagy. Experiments were scored for over 150 cells per condition in three or more independent experiments.",
          "judgment": "Yes",
          "reasoning": "Both normal (wild-type Parkin) and abnormal (various mutants) controls are used, and the paper explicitly states multiple independent experiments with large sample sizes, indicating replicates were performed.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Wild-type Parkin was used as a control for recruitment and mitophagy, alongside other known pathogenic Parkin mutants (e.g., C253Y, C289G) which failed to show normal recruitment or mitophagy.",
          "judgment": "Yes",
          "reasoning": "Known pathogenic variants (e.g., C253Y, C289G) were tested as controls, providing a benchmark for loss-of-function effects in the assay, meeting the criteria for variant controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper reports percentages of cells with Parkin recruitment (e.g., 94.7% for wild-type Parkin vs. 34% for R42P) and mitophagy (59% for wild-type vs. 22% for R42P) with standard deviation, but does not provide OddsPath or detailed statistical tests for pathogenicity likelihood.",
          "judgment": "No",
          "reasoning": "While percentages and standard deviations are provided, there is no explicit calculation of OddsPath or sufficient statistical analysis to quantify pathogenicity likelihood for individual variants.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study tested multiple Parkin variants as controls, including wild-type, R46P, C253Y, C289G, C441R, and others, totaling more than 10 variants across the experiments.",
          "judgment": "At least 11",
          "reasoning": "The total number of benign and pathogenic variant controls used in the study exceeds 10, meeting the threshold for a moderate evidence strength assignment.",
          "next_step_or_outcome": "Max PS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The Parkin R42P variant is assigned a PS3_moderate strength for pathogenicity due to its moderate deficit in Parkin recruitment (34% vs. 94.7% for wild-type) and mitophagy (22% vs. 59% for wild-type) in HeLa cells, supported by the use of multiple variant controls (over 10) and robust experimental design, despite the lack of OddsPath calculation."
    },
    {
      "variant_id": {
        "Gene": "Parkin",
        "Protein_Change": {
          "ref": "R",
          "alt": "P",
          "position": "46"
        },
        "variant_string_id": "Parkin R46P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in Parkin are linked to early-onset Parkinson disease through disruption of the PINK1/Parkin pathway, which is critical for mitochondrial quality control by promoting the selective elimination of damaged mitochondria via mitophagy.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as a failure in mitochondrial quality control due to disrupted PINK1/Parkin signaling, leading to accumulation of dysfunctional mitochondria and neuronal damage in Parkinson disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses confocal microscopy and immunoblotting to assess Parkin recruitment to depolarized mitochondria and mitophagy induction in HeLa cells, reflecting mitochondrial dysfunction relevant to Parkinson disease.",
          "judgment": "Yes",
          "reasoning": "The assays (confocal microscopy for localization and immunoblotting for protein expression) are relevant to the disease mechanism as they model mitochondrial dysfunction and the PINK1/Parkin pathway's role in mitophagy, which are central to Parkinson disease pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study includes wild-type Parkin as a positive control for recruitment and mitophagy. Experiments were scored for over 150 cells per condition in three or more independent experiments.",
          "judgment": "Yes",
          "reasoning": "Both normal (wild-type Parkin) and abnormal (various mutants) controls are used, and the paper explicitly states multiple independent experiments with large sample sizes, indicating replicates were performed.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Wild-type Parkin was used as a control for recruitment and mitophagy, alongside other known pathogenic Parkin mutants (e.g., C253Y, C289G) which failed to show normal recruitment or mitophagy.",
          "judgment": "Yes",
          "reasoning": "Known pathogenic variants (e.g., C253Y, C289G) were tested as controls, providing a benchmark for loss-of-function effects in the assay, meeting the criteria for variant controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper reports percentages of cells with Parkin recruitment (e.g., 94.7% for wild-type Parkin vs. 26.5% for R46P) and mitophagy (59% for wild-type vs. 23.1% for R46P) with standard deviation, but does not provide OddsPath or detailed statistical tests for pathogenicity likelihood.",
          "judgment": "No",
          "reasoning": "While percentages and standard deviations are provided, there is no explicit calculation of OddsPath or sufficient statistical analysis to quantify pathogenicity likelihood for individual variants.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study tested multiple Parkin variants as controls, including wild-type, R42P, C253Y, C289G, C441R, and others, totaling more than 10 variants across the experiments.",
          "judgment": "At least 11",
          "reasoning": "The total number of benign and pathogenic variant controls used in the study exceeds 10, meeting the threshold for a moderate evidence strength assignment.",
          "next_step_or_outcome": "Max PS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The Parkin R46P variant is assigned a PS3_moderate strength for pathogenicity due to its moderate deficit in Parkin recruitment (26.5% vs. 94.7% for wild-type) and mitophagy (23.1% vs. 59% for wild-type) in HeLa cells, supported by the use of multiple variant controls (over 10) and robust experimental design, despite the lack of OddsPath calculation."
    },
    {
      "variant_id": {
        "Gene": "Parkin",
        "Protein_Change": {
          "ref": "C",
          "alt": "Y",
          "position": "253"
        },
        "variant_string_id": "Parkin C253Y"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in Parkin are linked to early-onset Parkinson disease through disruption of the PINK1/Parkin pathway, which is critical for mitochondrial quality control by promoting the selective elimination of damaged mitochondria via mitophagy.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as a failure in mitochondrial quality control due to disrupted PINK1/Parkin signaling, leading to accumulation of dysfunctional mitochondria and neuronal damage in Parkinson disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses confocal microscopy and immunoblotting to assess Parkin recruitment to depolarized mitochondria and mitophagy induction in HeLa cells, reflecting mitochondrial dysfunction relevant to Parkinson disease.",
          "judgment": "Yes",
          "reasoning": "The assays (confocal microscopy for localization and immunoblotting for protein expression) are relevant to the disease mechanism as they model mitochondrial dysfunction and the PINK1/Parkin pathway's role in mitophagy, which are central to Parkinson disease pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study includes wild-type Parkin as a positive control for recruitment and mitophagy. Experiments were scored for over 150 cells per condition in three or more independent experiments.",
          "judgment": "Yes",
          "reasoning": "Both normal (wild-type Parkin) and abnormal (various mutants) controls are used, and the paper explicitly states multiple independent experiments with large sample sizes, indicating replicates were performed.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Wild-type Parkin was used as a control for recruitment and mitophagy, alongside other known pathogenic Parkin mutants (e.g., R42P, C289G) which failed to show normal recruitment or mitophagy.",
          "judgment": "Yes",
          "reasoning": "Known pathogenic variants (e.g., R42P, C289G) were tested as controls, providing a benchmark for loss-of-function effects in the assay, meeting the criteria for variant controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper reports percentages of cells with Parkin recruitment (e.g., 94.7% for wild-type Parkin vs. 0% for C253Y at 1h) and mitophagy (59% for wild-type vs. 0% for C253Y) with standard deviation, but does not provide OddsPath or detailed statistical tests for pathogenicity likelihood.",
          "judgment": "No",
          "reasoning": "While percentages and standard deviations are provided, there is no explicit calculation of OddsPath or sufficient statistical analysis to quantify pathogenicity likelihood for individual variants.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study tested multiple Parkin variants as controls, including wild-type, R42P, R46P, C289G, C441R, and others, totaling more than 10 variants across the experiments.",
          "judgment": "At least 11",
          "reasoning": "The total number of benign and pathogenic variant controls used in the study exceeds 10, meeting the threshold for a moderate evidence strength assignment.",
          "next_step_or_outcome": "Max PS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The Parkin C253Y variant is assigned a PS3_moderate strength for pathogenicity due to its complete failure in Parkin recruitment (0% vs. 94.7% for wild-type at 1h) and mitophagy (0% vs. 59% for wild-type) in HeLa cells, supported by the use of multiple variant controls (over 10) and robust experimental design, despite the lack of OddsPath calculation."
    },
    {
      "variant_id": {
        "Gene": "Parkin",
        "Protein_Change": {
          "ref": "C",
          "alt": "G",
          "position": "289"
        },
        "variant_string_id": "Parkin C289G"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in Parkin are linked to early-onset Parkinson disease through disruption of the PINK1/Parkin pathway, which is critical for mitochondrial quality control by promoting the selective elimination of damaged mitochondria via mitophagy.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as a failure in mitochondrial quality control due to disrupted PINK1/Parkin signaling, leading to accumulation of dysfunctional mitochondria and neuronal damage in Parkinson disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses confocal microscopy and immunoblotting to assess Parkin recruitment to depolarized mitochondria and mitophagy induction in HeLa cells, reflecting mitochondrial dysfunction relevant to Parkinson disease.",
          "judgment": "Yes",
          "reasoning": "The assays (confocal microscopy for localization and immunoblotting for protein expression) are relevant to the disease mechanism as they model mitochondrial dysfunction and the PINK1/Parkin pathway's role in mitophagy, which are central to Parkinson disease pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study includes wild-type Parkin as a positive control for recruitment and mitophagy. Experiments were scored for over 150 cells per condition in three or more independent experiments.",
          "judgment": "Yes",
          "reasoning": "Both normal (wild-type Parkin) and abnormal (various mutants) controls are used, and the paper explicitly states multiple independent experiments with large sample sizes, indicating replicates were performed.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Wild-type Parkin was used as a control for recruitment and mitophagy, alongside other known pathogenic Parkin mutants (e.g., R42P, C253Y) which failed to show normal recruitment or mitophagy.",
          "judgment": "Yes",
          "reasoning": "Known pathogenic variants (e.g., R42P, C253Y) were tested as controls, providing a benchmark for loss-of-function effects in the assay, meeting the criteria for variant controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper reports percentages of cells with Parkin recruitment (e.g., 94.7% for wild-type Parkin vs. 0% for C289G at 1h, with some recruitment at 24h) and mitophagy (59% for wild-type vs. 0% for C289G) with standard deviation, but does not provide OddsPath or detailed statistical tests for pathogenicity likelihood.",
          "judgment": "No",
          "reasoning": "While percentages and standard deviations are provided, there is no explicit calculation of OddsPath or sufficient statistical analysis to quantify pathogenicity likelihood for individual variants.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study tested multiple Parkin variants as controls, including wild-type, R42P, R46P, C253Y, C441R, and others, totaling more than 10 variants across the experiments.",
          "judgment": "At least 11",
          "reasoning": "The total number of benign and pathogenic variant controls used in the study exceeds 10, meeting the threshold for a moderate evidence strength assignment.",
          "next_step_or_outcome": "Max PS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The Parkin C289G variant is assigned a PS3_moderate strength for pathogenicity due to its initial complete failure in Parkin recruitment (0% vs. 94.7% for wild-type at 1h, with delayed partial recruitment at 24h) and mitophagy (0% vs. 59% for wild-type) in HeLa cells, supported by the use of multiple variant controls (over 10) and robust experimental design, despite the lack of OddsPath calculation."
    },
    {
      "variant_id": {
        "Gene": "Parkin",
        "Protein_Change": {
          "ref": "C",
          "alt": "R",
          "position": "441"
        },
        "variant_string_id": "Parkin C441R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in Parkin are linked to early-onset Parkinson disease through disruption of the PINK1/Parkin pathway, which is critical for mitochondrial quality control by promoting the selective elimination of damaged mitochondria via mitophagy.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as a failure in mitochondrial quality control due to disrupted PINK1/Parkin signaling, leading to accumulation of dysfunctional mitochondria and neuronal damage in Parkinson disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses confocal microscopy and immunoblotting to assess Parkin recruitment to depolarized mitochondria and mitophagy induction in HeLa cells, reflecting mitochondrial dysfunction relevant to Parkinson disease.",
          "judgment": "Yes",
          "reasoning": "The assays (confocal microscopy for localization and immunoblotting for protein expression) are relevant to the disease mechanism as they model mitochondrial dysfunction and the PINK1/Parkin pathway's role in mitophagy, which are central to Parkinson disease pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study includes wild-type Parkin as a positive control for recruitment and mitophagy. Experiments were scored for over 150 cells per condition in three or more independent experiments.",
          "judgment": "Yes",
          "reasoning": "Both normal (wild-type Parkin) and abnormal (various mutants) controls are used, and the paper explicitly states multiple independent experiments with large sample sizes, indicating replicates were performed.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Wild-type Parkin was used as a control for recruitment and mitophagy, alongside other known pathogenic Parkin mutants (e.g., R42P, C253Y) which failed to show normal recruitment or mitophagy.",
          "judgment": "Yes",
          "reasoning": "Known pathogenic variants (e.g., R42P, C253Y) were tested as controls, providing a benchmark for loss-of-function effects in the assay, meeting the criteria for variant controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper reports percentages of cells with Parkin recruitment (e.g., 94.7% for wild-type Parkin vs. 0% for C441R at 1h, with some recruitment at 24h) and mitophagy (59% for wild-type vs. 5.3% for C441R) with standard deviation, but does not provide OddsPath or detailed statistical tests for pathogenicity likelihood.",
          "judgment": "No",
          "reasoning": "While percentages and standard deviations are provided, there is no explicit calculation of OddsPath or sufficient statistical analysis to quantify pathogenicity likelihood for individual variants.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study tested multiple Parkin variants as controls, including wild-type, R42P, R46P, C253Y, C289G, and others, totaling more than 10 variants across the experiments.",
          "judgment": "At least 11",
          "reasoning": "The total number of benign and pathogenic variant controls used in the study exceeds 10, meeting the threshold for a moderate evidence strength assignment.",
          "next_step_or_outcome": "Max PS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The Parkin C441R variant is assigned a PS3_moderate strength for pathogenicity due to its initial complete failure in Parkin recruitment (0% vs. 94.7% for wild-type at 1h, with delayed partial recruitment at 24h) and severe deficit in mitophagy (5.3% vs. 59% for wild-type) in HeLa cells, supported by the use of multiple variant controls (over 10) and robust experimental design, despite the lack of OddsPath calculation."
    },
    {
      "variant_id": {
        "Gene": "Parkin",
        "Protein_Change": {
          "ref": "R",
          "alt": "W",
          "position": "275"
        },
        "variant_string_id": "Parkin R275W"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in Parkin are linked to early-onset Parkinson disease through disruption of the PINK1/Parkin pathway, which is critical for mitochondrial quality control by promoting the selective elimination of damaged mitochondria via mitophagy.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as a failure in mitochondrial quality control due to disrupted PINK1/Parkin signaling, leading to accumulation of dysfunctional mitochondria and neuronal damage in Parkinson disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses confocal microscopy and immunoblotting to assess Parkin recruitment to depolarized mitochondria and mitophagy induction in HeLa cells, reflecting mitochondrial dysfunction relevant to Parkinson disease.",
          "judgment": "Yes",
          "reasoning": "The assays (confocal microscopy for localization and immunoblotting for protein expression) are relevant to the disease mechanism as they model mitochondrial dysfunction and the PINK1/Parkin pathway's role in mitophagy, which are central to Parkinson disease pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study includes wild-type Parkin as a positive control for recruitment and mitophagy. Experiments were scored for over 150 cells per condition in three or more independent experiments.",
          "judgment": "Yes",
          "reasoning": "Both normal (wild-type Parkin) and abnormal (various mutants) controls are used, and the paper explicitly states multiple independent experiments with large sample sizes, indicating replicates were performed.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Wild-type Parkin was used as a control for recruitment and mitophagy, alongside other known pathogenic Parkin mutants (e.g., R42P, C253Y) which failed to show normal recruitment or mitophagy.",
          "judgment": "Yes",
          "reasoning": "Known pathogenic variants (e.g., R42P, C253Y) were tested as controls, providing a benchmark for loss-of-function effects in the assay, meeting the criteria for variant controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper reports percentages of cells with Parkin recruitment (e.g., 94.7% for wild-type Parkin vs. 81.7% for R275W) and mitophagy (59% for wild-type vs. 4% for R275W) with standard deviation, but does not provide OddsPath or detailed statistical tests for pathogenicity likelihood.",
          "judgment": "No",
          "reasoning": "While percentages and standard deviations are provided, there is no explicit calculation of OddsPath or sufficient statistical analysis to quantify pathogenicity likelihood for individual variants.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study tested multiple Parkin variants as controls, including wild-type, R42P, R46P, C253Y, C289G, and others, totaling more than 10 variants across the experiments.",
          "judgment": "At least 11",
          "reasoning": "The total number of benign and pathogenic variant controls used in the study exceeds 10, meeting the threshold for a moderate evidence strength assignment.",
          "next_step_or_outcome": "Max PS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The Parkin R275W variant is assigned a PS3_moderate strength for pathogenicity due to its severe deficit in mitophagy (4% vs. 59% for wild-type) despite only a mild deficit in recruitment (81.7% vs. 94.7% for wild-type) in HeLa cells, supported by the use of multiple variant controls (over 10) and robust experimental design, despite the lack of OddsPath calculation."
    },
    {
      "variant_id": {
        "Gene": "Parkin",
        "Protein_Change": {
          "ref": "K",
          "alt": "N",
          "position": "211"
        },
        "variant_string_id": "Parkin K211N"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in Parkin are linked to early-onset Parkinson disease through disruption of the PINK1/Parkin pathway, which is critical for mitochondrial quality control by promoting the selective elimination of damaged mitochondria via mitophagy.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as a failure in mitochondrial quality control due to disrupted PINK1/Parkin signaling, leading to accumulation of dysfunctional mitochondria and neuronal damage in Parkinson disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses confocal microscopy and immunoblotting to assess Parkin recruitment to depolarized mitochondria and mitophagy induction in HeLa cells, reflecting mitochondrial dysfunction relevant to Parkinson disease.",
          "judgment": "Yes",
          "reasoning": "The assays (confocal microscopy for localization and immunoblotting for protein expression) are relevant to the disease mechanism as they model mitochondrial dysfunction and the PINK1/Parkin pathway's role in mitophagy, which are central to Parkinson disease pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study includes wild-type Parkin as a positive control for recruitment and mitophagy. Experiments were scored for over 150 cells per condition in three or more independent experiments.",
          "judgment": "Yes",
          "reasoning": "Both normal (wild-type Parkin) and abnormal (various mutants) controls are used, and the paper explicitly states multiple independent experiments with large sample sizes, indicating replicates were performed.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Wild-type Parkin was used as a control for recruitment and mitophagy, alongside other known pathogenic Parkin mutants (e.g., R42P, C253Y) which failed to show normal recruitment or mitophagy.",
          "judgment": "Yes",
          "reasoning": "Known pathogenic variants (e.g., R42P, C253Y) were tested as controls, providing a benchmark for loss-of-function effects in the assay, meeting the criteria for variant controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper reports percentages of cells with Parkin recruitment (e.g., 94.7% for wild-type Parkin vs. 0% for K211N) and mitophagy (59% for wild-type vs. 0% for K211N) with standard deviation, but does not provide OddsPath or detailed statistical tests for pathogenicity likelihood.",
          "judgment": "No",
          "reasoning": "While percentages and standard deviations are provided, there is no explicit calculation of OddsPath or sufficient statistical analysis to quantify pathogenicity likelihood for individual variants.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study tested multiple Parkin variants as controls, including wild-type, R42P, R46P, C253Y, C289G, and others, totaling more than 10 variants across the experiments.",
          "judgment": "At least 11",
          "reasoning": "The total number of benign and pathogenic variant controls used in the study exceeds 10, meeting the threshold for a moderate evidence strength assignment.",
          "next_step_or_outcome": "Max PS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The Parkin K211N variant is assigned a PS3_moderate strength for pathogenicity due to its complete failure in Parkin recruitment (0% vs. 94.7% for wild-type) and mitophagy (0% vs. 59% for wild-type) in HeLa cells, supported by the use of multiple variant controls (over 10) and robust experimental design, despite the lack of OddsPath calculation."
    },
    {
      "variant_id": {
        "Gene": "Parkin",
        "Protein_Change": {
          "ref": "C",
          "alt": "Y",
          "position": "212"
        },
        "variant_string_id": "Parkin C212Y"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in Parkin are linked to early-onset Parkinson disease through disruption of the PINK1/Parkin pathway, which is critical for mitochondrial quality control by promoting the selective elimination of damaged mitochondria via mitophagy.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as a failure in mitochondrial quality control due to disrupted PINK1/Parkin signaling, leading to accumulation of dysfunctional mitochondria and neuronal damage in Parkinson disease."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses confocal microscopy and immunoblotting to assess Parkin recruitment to depolarized mitochondria and mitophagy induction in HeLa cells, reflecting mitochondrial dysfunction relevant to Parkinson disease.",
          "judgment": "Yes",
          "reasoning": "The assays (confocal microscopy for localization and immunoblotting for protein expression) are relevant to the disease mechanism as they model mitochondrial dysfunction and the PINK1/Parkin pathway's role in mitophagy, which are central to Parkinson disease pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The study includes wild-type Parkin as a positive control for recruitment and mitophagy. Experiments were scored for over 150 cells per condition in three or more independent experiments.",
          "judgment": "Yes",
          "reasoning": "Both normal (wild-type Parkin) and abnormal (various mutants) controls are used, and the paper explicitly states multiple independent experiments with large sample sizes, indicating replicates were performed.",
          "next_step_or_outcome": "Proceed to Step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Wild-type Parkin was used as a control for recruitment and mitophagy, alongside other known pathogenic Parkin mutants (e.g., R42P, C253Y) which failed to show normal recruitment or mitophagy.",
          "judgment": "Yes",
          "reasoning": "Known pathogenic variants (e.g., R42P, C253Y) were tested as controls, providing a benchmark for loss-of-function effects in the assay, meeting the criteria for variant controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper reports percentages of cells with Parkin recruitment (e.g., 94.7% for wild-type Parkin vs. 0% for C212Y) and mitophagy (59% for wild-type vs. 0% for C212Y) with standard deviation, but does not provide OddsPath or detailed statistical tests for pathogenicity likelihood.",
          "judgment": "No",
          "reasoning": "While percentages and standard deviations are provided, there is no explicit calculation of OddsPath or sufficient statistical analysis to quantify pathogenicity likelihood for individual variants.",
          "next_step_or_outcome": "Proceed to Step 4b"
        },
        {
          "step_name": "Step 4b: No OddsPath Calculation",
          "extracted_paper_info": "The study tested multiple Parkin variants as controls, including wild-type, R42P, R46P, C253Y, C289G, and others, totaling more than 10 variants across the experiments.",
          "judgment": "At least 11",
          "reasoning": "The total number of benign and pathogenic variant controls used in the study exceeds 10, meeting the threshold for a moderate evidence strength assignment.",
          "next_step_or_outcome": "Max PS3_moderate"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The Parkin C212Y variant is assigned a PS3_moderate strength for pathogenicity due to its complete failure in Parkin recruitment (0% vs. 94.7% for wild-type) and mitophagy (0% vs. 59% for wild-type) in HeLa cells, supported by the use of multiple variant controls (over 10) and robust experimental design, despite the lack of OddsPath calculation."
    }
  ]
}